"Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks."
"The criticism comes as Republican President Donald Trump's top health officials, including Health Secretary Robert F. Kennedy Jr., face growing pressure from abortion opponents to reevaluate mifepristone, which was approved 25 years ago and has repeatedly been deemed safe and effective by FDA scientists. In a letter to Republican attorneys general last month, Kennedy and FDA Commissioner Dr. Marty Makary pledged to conduct a full review of the drug's safety."
"Under Makary and Kennedy, the FDA has repeatedly delayed decisions on vaccines, ultimately narrowing the terms of approval for this year's COVID-19 shots. That type of political intervention was previously highly unusual at the FDA, where career scientists typically make such decisions. The FDA approved the original version of mifepristone in 2000 and gradually eased access over time. That included approving the first generic pill, from drugmaker GenBioPro, in 2019. In 2021, the FDA under Democratic President Joe Biden permitted online prescribing and mail-order deliver"
Federal officials approved another generic mifepristone from Evita Solutions, authorized to end pregnancies through 10 weeks and offered as a low-cost option. Anti-abortion groups and aligned Republican politicians swiftly criticized the approval, calling it a stain on the Trump presidency and saying it undermines confidence in FDA leadership. An FDA spokesperson said the agency has limited discretion in generic approvals and does not endorse products. Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary face pressure from opponents to reevaluate the drug and pledged a full safety review. The FDA originally approved mifepristone in 2000 and eased access over time.
Read at ABC7 Los Angeles
Unable to calculate read time
Collection
[
|
...
]